Demand for Monoclonal Antibodies and RNA Vaccines to Drive Cholesterol API Market Across Europe | Germany to Register 4.9% CAGR States FMI

The global Cholesterol Active Pharmaceutical Ingredient (API) Market is projected to be valued at US$ 269.0 Million by the end of 2022, and to grow at a CAGR of 4.7% between 2022 and 2032. By 2032, the global market for cholesterol API is expected to be worth US$ 426.9 Million. Germany is predicted to remain the most …

Popularity of Biopsy Devices in Minimally Invasive Procedures to Create Lucrative Opportunities for European Manufacturers | Introduction of Reimbursement Policies to Act as Catalyst

According to Future Market Insights (FMI), the U.K. Biopsy Device Market is poised to expand at a CAGR of 3.9% during the assessment period, reaching a valuation of US$ 159 Million by 2033. Germany’s biopsy device market is likely to accelerate at a CAGR of 4.1% during the anticipated timeframe with overall sales anticipated to hit a total of US$ 236 Million by the end …

Balloon Catheter Market exhibit a revenue growth of US$ 6.4 Billion by 2033

According to Future Market Insights (FMI), the U.K. Biopsy Device Market is poised to expand at a CAGR of 3.9% during the assessment period, reaching a valuation of US$ 159 Million by 2033. Germany’s biopsy device market is likely to accelerate at a CAGR of 4.1% during the anticipated timeframe with overall sales anticipated to hit a total of US$ 236 Million by the end …

Hematopoietic Stem Cell Transplantation to Hog Limelight in Europe from 2023 to 2033

As per the report published by Future Market Insights (FMI), the Hematopoietic Stem Cell Transplantation (HSCT) market in Europe is projected to accelerate at a CAGR of 7.6% from 2023 to 2033. Leukemia and lymphoproliferative disorders are among the most common types of medical conditions in Europe and reported cases have been steadily rising in recent years. This trend …

Korea’s Development of Petconomy is Changing the Way Companion Animal Specialty Drug Manufacturers Operate

South Koreans are expected to spend US$ 3 billion on their pets in 2020 and more than US$ 3.5 billion in 2021, resulting in an increase in pet-related businesses in Korea. According to the Korea Rural Economic Institute, this figure is expected to reach US$ 5 billion by 2027, creating opportunities for Korea’s companion animal specialty …

Knee Reconstruction Devices Market is anticipated to US$ 12.62 Billion by 2032

A rapidly growing demographic of geriatrics, advances in joint reconstruction technologies and procedures and higher incidence of osteoarthritis are key factors that support the developments in the global knee reconstruction devices market. By 2022, the market for knee reconstruction devices is projected to be worth US$ 8.28 billion, growing at a moderate CAGR of 4.3% between …

Dry Eye Syndrome Treatment Market a valuation of US$ 9.44 Billion by 2032

The global dry eye syndrome treatment market is size of the global market for the treatment of dry eye syndrome is anticipated to be US$ 4.80 billion in 2022 and to increase at a robust CAGR of 7.0% from 2022 to 2032, exceeding a valuation of US$ 9.44 billion by the end of 2032. One of …

Companion Animal Vaccines Market is expected to CAGR of 6.8% from 2023 to 2033

Remarkable increase in the companion animal ownership and strong growth of development of the veterinary healthcare infrastructure collectively push the companion animal vaccines sales in global market. Researchers at Future Market Insights, Inc. have noted that from 2023 to 2033, the market for companion animal vaccinations is anticipated to grow at a CAGR of 6.8%. By 2033, …

Orthopaedic Imaging Equipment Market is expected to reach US$ 14.6 Billion by 2031

According to a recent study by Future Market Insights (FMI), the global Orthopaedic imaging equipment market demand is expected reach US$ 9.8 Bn in 2021. Sales are expected to increase at a CAGR of around 4.0% over the forecast period (2021-2031). The market for orthopaedic imaging equipment was estimated at $9.8 billion in 2021 and is anticipated to grow to $14.6 billion by …

Radiopharmaceuticals Market is anticipated to value CAGR of 4.3% to reach US$ 9.5 Billion 2022 to 2032

Future Market Insights predicts that shorter half-life of radiopharmaceuticals, and lack of specified guidelines for their use in commercial-scale drug production will restrict the market from growing at higher rate. In the years to come, ageing research reactors from all corners of the world will be closed, which will significantly bring down global production of radiopharmaceuticals. …